Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print.
BackgroundPatients with acute promyelocytic leukemia (APML) undergoing induction therapy are severely immunocompromised and prone to opportunistic infections. Tuberculosis (TB), though less commonly considered, can complicate the clinical course, …